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Abstract
Background: Research into asthma is proceeding at an unprecedented rate and yet we live with a disease that escalates in prevalence and severity, 
despite a greater understanding of its pathophysiology and the necessary therapy. The total prevalence of asthma is estimated to lie at 7.2% of the 
world’s population (6% in adults, 10% in children). Data from Australia, Canada and Spain report that acute asthma accounted for 1 to 12% of all adult 
emergency department visits. The prevalence of asthma in South Africa lies at 5% for adults and 10% for children. Asthma is reported as taking up 1 
to 2% of the total health budget in direct costs, with equally large indirect costs being incurred for time lost from work and reduced productivity. It has 
also been reported that approximately one-third of the direct care costs of asthma are attributable to emergency department visits and hospitalisations. 
In some cases, exposure may be unavoidable (for example exposures to cold air, exercise or the asthma-inducing effects of pregnancy). Many studies 
have been done in other countries on specific triggers, especially allergens and viral respiratory infections. However, circumstances differ in the public 
sector in South Africa and other factors such as compliance and under-treatment, which may be applicable, should be studied in contention. 
Methods: A matched case-control study was undertaken  matched on age and gender  between December 2003 and May 2005. Known asthma 
patients with exacerbations presenting at Kalafong Hospital’s emergency unit were chosen as cases. Controls were stable asthma patients recruited 
from the outpatient departments. A structured questionnaire was used to interview patients concerning their possible exposure to certain triggers and 
risk factors. Univariate and multivariate analyses with conditional logistic regression were done to determine any significant exposures. Participants 
were between 18 and 65 years of age.
Results: In total, 356 patients were evaluated. Fifty cases and 100 controls were enrolled. Cases were shown to be more non-compliant than 
controls (OR = 2.18; 95% Confidence interval (CI): 1.09 to 4.38, p = 0.03). Missing follow-up doctor’s appointments for the last six months were 
statistically significant with an OR of 2.39 (95% CI 1.08 to 5.27) and p = 0.03. 
Conclusions: Non-compliance was a strong predictor of exacerbations in adult asthma patients at Kalafong Hospital. 
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Background
Research into asthma is proceeding at unprecedented rates and yet 
we live with a disease that is escalating in prevalence and severity, 
despite a greater understanding of its pathophysiology and the 
necessary therapy.1–4 The total prevalence of asthma is estimated to 
lie at 7.2% of the world’s population (6% in adults, 10% in children).5 
Data from Australia, Canada and Spain report that acute asthma 
accounts for 1 to 12% of all adult Emergency Department (ED) visits.6 
The prevalence of asthma in South Africa lies at 3.8% for adults7 (3% 
for males and 4.4% for females)8 and 13.3% for adolescents.9 Green 
et al report that asthma takes up 1 to 2% of the total health budget in 
direct costs, with equally large indirect costs being incurred for time lost 
from work and reduced productivity.10 Osur states that approximately 
one-third of the direct care costs of asthma are attributable to ED visits 
and hospitalisations.2
The reasons for rising rates of morbidity and mortality connected 
with asthma are unclear. Case-control studies using retrospectively 
collected data have suggested that excess use of short-acting ß-
agonists and under-use of inhaled corticosteroids may be associated 
with this phenomenon, although more recent data suggest that 
patterns of ß2-agonist use may be a marker of more severe asthma 
rather than a causal factor.1 
The beneficial effects of inhaled steroids when used as maintenance 
therapy in chronic asthma are well known. When used regularly, 
inhaled steroids decrease the number of asthma exacerbations 
caused by most triggers, including exercise.11 This fact has also been 
recognised in a Cape Town study, in which it was concluded that 
practitioners should increase the use of current asthma guidelines, as 
under-treatment is a huge problem.12
Patients at any level of severity – from mild intermittent to severe 
persistent – can have exacerbations. Each patient with asthma 
responds to a unique set of triggers. In some cases, exposure may 
be unavoidable (for example, exposures to cold air, exercise or the 
asthma-inducing effects of pregnancy).13 
Many triggers can provoke asthma exacerbations. According to the 
literature the following are possibilities: (1) inhalant irritants such as 
passive smoke (cigarette) exposure1,4,13,14 and diesel exhaust fumes;15 
(2) inhalant allergens such as house dust mites;2,4,14 (3) adverse 
drugs;13,16 (4) poor adherence/non-compliance to therapy;13,17 (5) 
extremes in weather or temperatures;13 (6) exercise;4 (7) respiratory 
infections;18–20 (8) strong emotions,13,21 etc.
Many studies have been done in other countries on specific triggers, 
especially allergens and viral respiratory infections. However, 
circumstances differ in the public sector in South Africa, and other 
factors such as compliance and under-treatment, which may be 
applicable in this context, should be studied in contention. 
Methods
The setting for this study was the emergency unit, the primary health 
clinic and the asthma clinics at the secondary family medicine and 
internal medicine outpatient departments at Kalafong Hospital, a 
secondary regional and teaching hospital affiliated to the University 
of Pretoria. The study population consisted of adult asthma patients 
between 18 and 65 years of age, who were representative of the 
communities served by Kalafong Hospital. 
The study design used was a matched case-control study – matched 
on age and gender. Each of the cases was matched with two controls. 
Known asthma patients were considered cases if they had developed 
an acute asthma exacerbation, defined as shortness of breath, 
chest tightness, wheezing and a peak expiratory flow rate (PEFR) 
that was at least 15 to 25% less than normal, requiring an ED visit, 
between December 2003 and May 2005. Known asthma patients 
were considered controls if they had had no exacerbations requiring 
emergency visits during the preceding month. Controls were recruited 
from the primary health clinic, secondary family medicine clinic and the 
internal medicine outpatients department. 
Inclusion criteria for study participants
Inclusion criteria for the study participants consisted of the following:
•  Diagnosis of asthma according to the National Guidelines 
of Management of Asthma in Adults at the Primary Level: 
Department of Health Directorate: Chronic Diseases, Disabilities 
and Geriatrics.22
•  Duration of asthma of more than one year.
•  Attendance of an asthma clinic at the family medicine or internal 




•  Any history of smoking
•  Self-diagnosed asthma
•  Newly diagnosed asthma
•  Pulmonary embolism
•  Active pulmonary tuberculosis
•  Chronic Obstructive Pulmonary Disease (COPD)
•  Congestive heart failure
•  Cough secondary to medications (e.g. angiotensin-converting 
enzyme inhibitors)
•  Mechanical obstruction (e.g. tumour)
•  Pulmonary eosinophilic infiltration
•  Vocal cord dysfunction
A complete sampling of all cases that met the inclusion criteria was 
done. In total, 444 asthma patients were treated at the unit between 
December 2003 and May 2005. Of these, 356 patients were evaluated 
by the investigator. Fifty patients fitted the inclusion criteria and were 
included in the study as cases. 
The investigator used a structured questionnaire as a basis for 
interviewing the participants, after obtaining informed consent from 
the participants to interview them. Information obtained from the 
questionnaire about exposure to possible triggers included age, 
gender, compliance, literacy, allergic rhinitis, infections, exercise, 
passive smoking, in-house coal fires, adverse drugs, stress/anxiety, 
exposure to household pets, premenstrual/menstrual phases, 
pregnancy, work-related exposures and under-treatment. Exposure 
to triggers was noted for the previous four weeks in both cases and 
controls. 
Definitions of possible trigger/risk factors
The definitions of the possible trigger/risk factors are set out below.
1. Non-compliance
  Non-compliance was identified as a trigger/risk factor when 
participants missed one or more doctor’s appointment in the past 
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six months, or missed one or more script appointment in the past 
six months or did not take medication as prescribed. The patients 
were required to describe exactly how they used their medication, 
and this was compared to the prescriptions in their files. The 
doctor and script appointments were available from each patient’s 
file.
2. Literacy level
 The following four sub-groups were included:
 1. No schooling
 2. Some primary schooling
 3. Some high school training
 4.  Matriculation
 A low literacy level was seen as a trigger/risk factor.
3. Severity of the chronic phase of asthma
  The following four sub-groups were investigated in accordance 
with the Guidelines for the Management of Chronic Asthma in 
Adults – 2000 Update.23
 1. Mild intermittent
 2. Mild persistent
 3. Moderate persistent
 4. Severe persistent
  A high level of severity of chronic asthma was seen as a trigger/
risk factor.
4. Under-treatment
  The prescribed medication of the patient was evaluated against 
the severity of the chronic phase of the patient’s asthma as 
specified in the guidelines for the management of chronic asthma 
in adults.23 Under-treatment was defined as the omission of 
corticosteroid inhalers to patients who qualified for treatment 
with them or the prescription of inappropriate dosages of inhaled 
corticosteroids. All insufficient prescriptions were seen as a trigger/
risk factor. 
5. Exercise/sport
  Participation in any formal or informal sport activities was seen 
as a possible trigger/risk factor for an asthma exacerbation. This 
included walking distances of at least 1 km.
6. Viral infections
  A viral infection was seen as a trigger/risk factor when at least 
three of the following five components on the questionnaire were 
marked positive:
 1. Sore throat
 2. Fever
 3. Runny/blocked nose
 4. Muscle aches
 5. Exposure to other people with a cold
7. Household pets
  This trigger/risk factor was restricted to cats or caged birds in the 
house or in the direct work place.
8. Passive smoking
  Passive tobacco smoking indoors at home, at the work place or at 
any other institution was seen as a trigger/risk factor.
9. Strong emotions
  The following types of strong emotion were considered as trigger/
risk factors:
 1. Anger
   Anger was seen as a trigger/risk factor when a participant had 
any loss of temper.
 2. Excitement
   Excitement was seen as a trigger/risk factor when a 
participant was extremely excited or happy about something, 
such as gifts, sports, finances or relationships.
 3. Anxiety
   Anxiety was seen as a trigger/risk factor when a participant was 
anxious for reasons related to crime or the death of a relative, for 
example, or when the participant was having an anxiety attack.
10. Coal stoves
  Exposure of participants to in-house wood burning or to coal 
stoves was seen as a trigger/risk factor.
11. Weather
  Weather was seen as a trigger/risk factor for all participants 
experiencing rainy weather conditions during their exposure 
assessment period. 
12. Medication
  The following types of medication were considered as trigger/risk 
factors:
 Nonsteroidal anti-inflammatory drugs (NSAIDs)
  Any orally ingested, rectally inserted or injected NSAID received 
by participants was seen as a trigger/risk factor for acute asthma 
exacerbations.
 β-blockers
  Any β-blocker-containing medication was seen as a trigger/risk factor. 
This included eye drops, intravenous preparations and tablets.
13. Allergic rhinitis
  Allergic rhinitis was seen as a trigger/risk factor when symptoms 
were present for more than one hour per day over two weeks 
and when at least two of the following four components on the 
questionnaire were marked positive:
 1. Blocked nose
 2. Sneezing
 3. Runny nose
 4. Seasonal symptoms
15. Work-related exposures
  Work-related exposures were seen as a trigger/risk factor when 
participants were exposed to, for example, spray-painting, 
diisocyanate or when they were employed in the pharmaceutical, 
plastics or platinum industries.
16. Pregnancy, menopause, and premenstrual/menstrual phases
  All female participants were evaluated regarding pregnancy, 
menopause or their menstrual cycles. Pregnancy was diagnosed 
with a positive β-human chorionic gonado trophins (β-HCG) blood 
test and menopause was established from a history of normal 
cessation of menstruation. Premenstrual/menstrual phases 
were seen as a possible trigger/risk factor for cases in their 
premenstrual or menstrual phase during an exacerbation and for 
controls with no amenorrhoea in the previous four weeks.
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Prescribed medication 
Prescribed medication was recorded from the patients’ files. This 
included β-agonist-, ipratropium bromide, beclomethasone and 
budesonide inhalers, oral theophylline, long-acting β2-agonists and 
daily oral steroids. 
Statistical package used
Univariate statistical analysis was done to assess characteristics and 
risk factors of participants. The Intercooled Stata 8.1 (Intercooled for 
Table I: Characteristics of study participants









Male 8 (16%) 16 (16%) N/A









a. NS* 6 (12%) 20 (20%)
b. SPS† 14 (28%) 29 (29%) 1.68 0.55–5.16 0.37
c. SHT‡ 13 (26%) 35 (35%) 1.36 0.42–4.46 0.61
d. M§ 17 (34%) 16 (16%) 4.60 1.26–6.79 0.02
2. Severity 0.36
a. MIII 10 (20%) 19 (19%)
b. MP** 18 (36%) 32 (32%) 1.14 0.43–3.02 0.79
c. Mod P†† 19 (38%) 48 (48%) 0.79 0.30–2.07 0.64
d. SP‡‡ 3 (6%) 1 (1%) 5.77 0.51–65.86 0.16
3.  Non-
    compliance 32 (64%) 44 (44%) 2.18 1.09–4.38 0.03
4.  Under-
treatment 8 (16%) 11 (11%) 1.57 0.57–4.33 0.38
5. Exercise 22 (44%) 48 (48%) 0.80 0.36–1.79 0.59
6.  Viral 
infections 16 (32%) 23 (23%) 1.50 0.74–3.05 0.26
7. Pets: cats 4 (8%) 10 (10%) 0.79 0.24–2.61 0.70
8.  Passive 
smoke 18 (36%) 26 (26%) 1.66 0.77–3.58 0.19
9.  Emotions: 
a. anger 21 (42%) 41 (41%) 1.05 0.51–2.13 0.90
b. excitement 15 (30%) 40 (40%) 0.64 0.31–1.33 0.24
c. anxiety 11 (22%) 23 (23%) 0.95 0.42–2.11 0.89
10. Coal stoves 4 (8%) 4 (4%) 2.00 0.50–8.00 0.33
11.  Weather: 
rain 41 (82%) 90 (90%) 0.00 0.00–∝ 1.00
12. NSAIDs 20 (40%) 34 (34%) 1.32 0.64–2.76 0.45
13. β-blockers 0 (0%) 1 (1%) 0.00 0.00–∝ 1.00
14.  Allergic 
rhinitis 4 (8%) 11 (11%) 0.70 0.21–2.35 0.56
15. Work-related 4 (8%) 2 (2%) 4.00 0.73–21.84 0.11
16. Females:
a. pregnancy 2 (4.8%) 1 (1.2%) 4.00 0.36–44.11 0.26
b. menopause 16 (38.1%) 39 (46.4%) 0.38 0.10–1.49 0.17
c.  menstrual/ 
premenstrual 23 (54.8%) 42 (50%) 1.56 0.49–4.93 0.45
* NS No schooling
† SPS Some primary schooling
‡ SHT Some high school training
§ M Matriculation
II MI Mild intermittent 
** MP Mild persistent 
†† Mod P Moderate persistent 
‡‡ SP Severe persistent 
Windows; STATA Corp, College Station, Tex; 2003) statistical package 
was used. Student’s t-test was used for continuous data. Conditional 
logistic regression was used for multivariate analysis. 
Ethical considerations
The Ethics Committee of the Faculty of Human Health Sciences of the 
University of Pretoria authorised the study, which was conducted in 
accordance with the ethical principles of the Declaration of Helsinki and 
Geneva Declaration of the World Medical Association.
Results
A total of 150 patients were recruited: 50 cases with acute asthma 
exacerbations, from the emergency unit, and 100 controls with stable 
asthma, from the outpatient departments. Results (see Table I) revealed 
that cases were more likely than controls not to comply with treatment 
(OR = 2.18; 95% CI 1.09 to 4.38; p = 0.03). According to responses 
to the questionnaire, respiratory viral infections were present in 32% 
of cases and in 23% of controls. The literacy level (matriculation) was 
higher in cases than controls – 34% versus 16%.
Females were more likely to be included in the study, as 84% of 
participants were females and only 16% were males. Under-treatment 
was detected in less than 20% of cases and controls. Rainy weather 
was present in 82% of cases and also in 90% of controls. More female 
controls (46%) than cases (38%) were in their menopause. Although 
more cases than controls were exposed to passive smoke (36% versus 
26%) and to non-steroid anti-inflammatory drugs (40% versus 34%), 
these results were not statistically significant. 
The parameters used to determine non-compliance are shown in Table II. 
Only one of the three parameters needed to be fulfilled in order to mark 
a participant as not complying. “Missing follow-up appointments in the 
last six months” was statistically significant, with an OR of 2.39 (95% CI 
1.08 to 5.27) and p = 0.03. 
Table II: Exposition of compliance of study participants










past 6 months 
16 (32%) 16 (16%) 2.39 1.08–5.27 0.03
Missed script 
appointment(s) 
past  6 months 
19 (38%) 24 (24%) 2.18 0.96–4.93 0.06
Meds not taken as 
prescribed 20 (40%) 27 (27%) 1.78 0.87–3.62 0.11
Analysis of the case-control data was also done with conditional logistic 
regression to assess clinically relevant and statistically significant 
variables identified in the univariate analysis. The final model consisted 
of the dependent variable (case/control) and non-compliance. The odds 
ratio was found to be 2.82 with CI 1.31 to 6.10; p = 0.008.  
 
In Table III all the medication prescribed for the cases and controls 
is shown. There was no difference of note between the cases and 
controls. Daily oral steroids were prescribed for six cases − only three 
of these cases had severe persistent asthma in the dataset − and 
for eight controls, with only one severe persistent participant. One 
participant received two β-agonist inhalers and another participant 
did not receive a budesonide inhaler from the pharmacy although it 
was prescribed. In total, 88% of cases and 93% of controls were on 
inhaled corticosteroids. 
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β2-agonist inhaler 47 (94%) 97 (97%) 0.25 0.02–2.76 0.26
Ipratropium bromide 
inhaler 1 (2%) 2 (2%) 1 0.09–11.03 1.00
Beclomethasone 
inhaler 11 (22%) 29 (29%) 0.69 0.31–1.54 0.36
Budesonide inhaler 33 (66%) 64 (64%) 1.23 0.65–2.32 0.52
Oral theophylline 31 (62%) 64 (64%) 0.92 0.45–1.86 0.81
Long-acting β-
agonist inhaler 1 (2%) 3 (3%) 0.67 0.07–6.41 0.73
Oral steroids 6 (12%) 8 (8%) 1.55 0.51–4.69 0.44
Discussion
This was a matched case-control study, investigating the potential 
triggers or risk factors causing exacerbations in known adult asthma 
patients in a hospital setting. A significant association was shown 
between non-compliance and asthma exacerbations. Compliance was 
determined by (1) evaluating the patients’ records to decide whether 
they kept follow-up appointments; (2) evaluating the prescription 
chart for script follow-ups; and (3) interviewing each patient to assess 
whether they used medication as prescribed. According to the 
literature, poor adherence to therapy is a common phenomenon.17 
Social class might have been a potential confounding factor here, but 
the controls and cases were selected from the same environment and 
communities. This effectively matched for social class and indicated 
that the results are unlikely to be the result of misclassifications. Many 
of the patients who did not keep follow-up appointments complained 
about money and transport problems. 
The literacy level (matriculation) was higher in cases than in controls. 
One can therefore speculate that education would not decrease 
the number of asthma exacerbations. Under-usage of inhaled 
corticosteroids was one of the major elements that surfaced in 
response to interview questions on the use of prescribed medication. 
This has also been found in other studies.1,10 A study conducted 
by Green et al,3 for example, found that patients did not know the 
difference between controller and reliever treatment. 
According to some studies, 40 to 50% of asthma exacerbations 
are caused by viral upper respiratory infections.2,18 A British study 
undertaken by Green et al10 in a large district hospital detected viruses 
in 26% of acute asthma and 18% of stable asthma control patients 
with polymerase chain reaction (PCR) assays. This study found 
that viral infection was noticeably less common in adults admitted to 
hospital with acute asthma than in children or adults having asthma 
exacerbations in the community.10 In our study the odds ratio for viral 
infections in the exposure assessment was only 1.5 (p = 0.26). This 
could be ascribed to the high occurrence (23%) of viral infections in the 
controls. Green et al explained this phenomenon, which also occurred 
in their study (controls of 18%), by stating that patients with asthma 
are more susceptible to viral infections than patients without asthma, 
but that such an infection may not necessarily induce a deterioration 
in asthma to the point where hospital admission is required.10 Tan et 
al. confirm this in their study in which viruses were recovered from 
asymptomatic adolescents with asthma.18 This finding corresponds 
with the findings of our study. 
The definitive diagnosis of respiratory viral infections is complicated 
by the lack of commercial availability of a rapid and cost-effective 
laboratory test to confirm the presence of viral respiratory infections.18 
In this study questionnaires, and not cultures of nasopharyngeal swabs 
and serology, were used to evaluate the presence of respiratory viral 
infections. According to Osur, polymerase chain reaction (PCR) is only 
available in the research setting. Therefore, in the evaluation of typical 
viral infections, clinical signs and symptoms are the clinician’s only tool 
for establishing the diagnosis of viral respiratory infections.2
Although the approach of self-administered questionnaires or 
interviews was cost-effective, the quality of this data was variable, 
in part because many exposures were inherently difficult to specify 
and quantify, and in part because of the difficulty the participants 
experienced in recalling events that had occurred in the past. Some of 
these inaccuracies could be reduced with careful questionnaire design 
but even with the best design considerable exposure misclassification 
might be expected.
In accordance with a Canadian study,24 our controls were chronic 
asthmatics with no exacerbations during the preceding four weeks, 
selected from the asthma clinics at Kalafong Hospital. Controls were 
selected longitudinally throughout the course of the study (density 
sampling). This did not involve a random sample of the person-time in 
the study base since controls were only sampled for the ‘instantaneous’ 
time periods in which cases occurred. Controls could become cases 
later during the study, but cases could not become controls.
Limitations
This study cannot be generalised beyond the study population, as it 
involved patients within the public sector and at a single centre.
Definitive diagnosis of respiratory viral infections was not done with the 
use of laboratory tests such as serology, culture confirmation or PCR. 
Questionnaires on clinical symptomatology were used instead. 
Recommendations
Self-management should be an important goal for asthma patients. 
The key features of a self-management programme would be a written 
action plan, the monitoring of asthma symptoms and the scheduling 
of regular reviews.17 Doctors could help patients follow their self-
management programme. 
A pharmacist care programme in which the pharmacist monitors 
symptoms, provides medication counselling, helps resolve drug-related 
problems and facilitates communication with the patients’ doctors may 
be able to enhance patients’ adherence to therapy and outcomes.25
Patients with asthma should be motivated and receive education on 
the proper and regular use of inhalers. Doctors should also explain 
to them the appropriate dosing according to the severity level of their 
asthma in order to promote compliance.
Conclusion
To conclude, non-compliance was a strong predictor of exacerbations 
in adult asthma patients at Kalafong Hospital, which forms part of a 
third world community. Viral infections were, however, still common 
in cases without inducing deterioration in asthma to the point where 
hospital admission was required.
References
1.  Turner MO, Noertjojo K, Vedal S, Bai T, Crump S, Fitzgerald JM. Risk factors for near-
fatal asthma. Am J Respir Crit Care Med 1998;157:18049.
2.  Osur SL. Viral respiratory infections in association with asthma and sinusitis: A review. 
Ann Allergy Asthma Immunol 2002;89:55360.
3.  Green RJ, Greenblatt MM, Plit M, Jones S, Adam B. Asthma management and 
perceptions in rural South Africa. Ann Allergy Asthma Immunol 2001;86:3437.
4.  Lemanske RF, Busse WW. Asthma. J Allergy Clin Immunol 2003;111 Suppl 2:50219.
5.  Merckmedicus.com [homepage on the Internet], New York: Asthma, Merck & Co. 
[updated 2001 March]. Available from:     http://www.merckmedicus.com/pp/us/hcp/
diseasemodules/asthma/default.jsp (Accessed 05/12/2005).
6.  Rodrigo GJ, Rodrigo C, Hall B. Acute asthma in adults. Chest 2004;125(3):1081102.
7.  Ehrlich RI, White N, Norman R, et al. Wheeze, asthma diagnosis and medication use: 
A national adult survey in a developing country. Thorax 2005;60:895901.
8.  SA Demographic & Health Survey 2003. DOH & MRC Report. Available from: http:
//www.doh.gov.za/facts/sadhs2003/part2.pdf   (Accessed  03/12/2007).
9.  Poyser MA, Nelson H, Ehrlich RI, et al. Socioeconomic deprivation and asthma 
prevalence and severity in young adolescents. Eur Respir J 2002;19:8928.
10.  Green RM, Custovic A, Sanderson G, Hunter J, Johnston SL, Woodcock A. 
Synergism between allergens and viruses and risk of hospital admission with asthma: 
Case-control study. BMJ 2002;324:76372.
11.  Tan RA, Spector SL. Exercise-induced asthma: Diagnosis and management. Ann 
Allergy Asthma Immunol 2002;89:22636.  
12.  Ehrlich RI, Jordaan E, Du Toit D, Volmink JA, Weinberg E, Zwarenstein M. 
Underrecognition and undertreatment of asthma in Cape Town primary school 
children. S Afr Med J 1998;88:98694.   
13.  Reinke LF, Hoffman L. Asthma education: creating a partnership. Heart Lung 
2000;29:22536.
14.  Peebles RS, Hartert TV. Highlights from the annual scientific assembly: Patient-
centered approaches to asthma management: strategies for treatment and 
management of asthma. South Med J 2002;95:7759.  
15.  Peden DB. Pollutants and asthma: role of air toxics. Environ Health Perspect 
2002;110 Suppl 4:5658.  
16.  Andreoli TE, Carpenter CCJ, Plum F, Lloyd HS, eds. Cecil essentials of medicine. 
Philadelphia: W B Saunders Company; 1986. 
17.  Sawyer SM. Action plans, self-monitoring and adherence: Changing behaviour to 
promote better self-management. Med J Aust 2002;177 Suppl:724.  
18. Johnston SL. Viruses and asthma. Allergy 1998;53(10):92232.  
19.  Isaacs D, Joshi P. Respiratory infections and asthma. Med J Aust 2002;177 Suppl:
501.  
20.  Clementsen P, Permin H, Norn S. Chlamydia pneumoniae infection and its role in 
asthma and chronic obstructive pulmonary disease. J Investig Allergol Clin Immunol 
2002;12:739.  
21.  Von Leupoldt A, Dahme B. Emotions and airway resistance in asthma: Study with 
whole body pletysmography. Psychophysiology 2005;42(1):92.
22.  National Guideline on Management of Asthma in. Adults at Primary Level 2002 
December. Available from: http://www.doh.gov.za/docs/ (Accessed 03/10/2006).
23.  Lalloo UG, Bateman ED, Feldman C, et al. Guidelines for the management of chronic 
asthma in adults  2000 update. S Afr Med J May 2000;90(5pt2):5401, 54452. 
24.  Tarlo SM, Broder I, Corey P, et al. A case-control study of the role of cold symptoms 
and other historical triggering factors in asthma exacerbations. Can Respir J 2000;7:
428.  
25.  Weinberger M, Murray MD, Marrero DG. Effectiveness of pharmacist care for patients 
with reactive airways disease. JAMA 2002;288(13):1594602.
Original Research
SA Fam Pract 2008                  Vol 50 No 467e
